Stay updated on Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe study’s record history now indicates an update to its references. A sitewide NIH notice about replacing “Artificial Intelligence” with “Super Intelligence” also appears.SummaryDifference0.5%

- Check11 days agoChange DetectedThe ClinicalTrials.gov site footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check18 days agoChange DetectedThe ClinicalTrials.gov page footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check39 days agoChange DetectedAdded a new system revision entry, Revision: v3.7.0, to the study record history and removed the previous Revision: v3.6.6 entry. This reflects a platform update affecting how revisions are labeled in the history view, not changes to the study data.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision: v3.6.6 was added to replace v3.6.5 in the record history, indicating a software update to the page's revision-tracking UI.SummaryDifference0.1%

- Check74 days agoChange DetectedThe References section header was removed from the record history view, reducing access to the cited sources and background information for this trial.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage III Melanoma Clinical Trial page.